Europe's biggest banks are pulling in opposite directions on income and returns even as capital ratios thin out from Tokyo to Wall Street.

Net interest income rose 10% year-over-year to $25.6 billion in the second quarter.

Honeywell saw a complete withdrawal from eight institutional holders while Intel experienced fragmented positioning shifts.

The biopharmaceutical company reduced its full-year adjusted diluted EPS range to $13.91 - $14.11 following a $10.9 billion deal for Apogee Therapeutics.

Across 130 companies issuing quarterly outlooks, raises outnumbered cuts roughly ten to one, with semiconductor, software and hardware makers reporting no lowered guidance at all.

In first-quarter 2026 filings across 168 domestic companies, cost inflation ran more than five to one negative while demand and capital spending held their ground.

The electric vehicle maker delivered 480,126 vehicles in the second quarter of 2026.

Companies describe resilient demand and steady capital spending this quarter, but input-cost inflation, hiring caution and consumer strain dominate what management teams disclosed.

The chipmaker posted $25.11 in non-GAAP earnings per share, more than double the prior quarter, as data-center memory revenue nearly tripled year over year.

The acquisition adds clinical-stage immunology assets in atopic dermatitis and asthma, deepening AbbVie's respiratory pipeline.

The heavy-equipment maker posted adjusted earnings of $5.54 a share for the quarter.

The internet giant’s Google Cloud backlog nearly tripled to $460 billion in the quarter.

The chipmaker’s AI semiconductor sales more than doubled to $10.8 billion in the quarter.

The networking giant raised its full-year revenue guidance to as much as $63 billion after a 12% jump in sales.

Microsoft Cloud revenue reached $54.5 billion, up 29% from a year earlier.

Meta raised its 2026 capital-spending outlook to $125 billion to $145 billion as data-center costs climbed.

The e-commerce giant reported $30.3 billion in net income, including $16.8 billion in pre-tax gains from Anthropic investments.

Adjusted earnings fell 2.5% to $2.70 a share, putting margin pressure at the center of Johnson & Johnson's higher 2026 outlook.